Fjarde AP Fonden Fourth Swedish National Pension Fund Has $11.37 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 37,869 shares of the company’s stock after acquiring an additional 1,600 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in HCA Healthcare were worth $11,366,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in HCA. Legacy Investment Solutions LLC bought a new position in HCA Healthcare in the 3rd quarter worth approximately $39,000. Activest Wealth Management boosted its holdings in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares during the period. Canoe Financial LP bought a new position in shares of HCA Healthcare during the 3rd quarter worth about $41,000. Capital Performance Advisors LLP bought a new stake in shares of HCA Healthcare in the third quarter valued at about $41,000. Finally, Pinnacle Bancorp Inc. increased its stake in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after acquiring an additional 50 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on HCA shares. Oppenheimer boosted their price objective on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. Truist Financial dropped their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Bank of America lowered their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 27th. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Price Performance

Shares of HCA stock opened at $316.07 on Monday. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The firm’s 50 day moving average is $313.53 and its 200-day moving average is $350.82. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The firm has a market capitalization of $78.49 billion, a price-to-earnings ratio of 14.39, a PEG ratio of 1.10 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the company earned $5.90 earnings per share. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.91%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.